EUVIMEDEUVIMED entdecken
Crossref

Probe-general NIR-II in vivo lock-in fluorescence imaging with superior contrast

Xuhao Yu, Rongyuan Zhang, Zhen Tian, Yixuan Chen, Jiachen Zhang, Yue Yuan, Zheng Zhao, Ben Zhong Tang, Dazhi Hou

Photonics Research · 01.09.2026 · 14 (9) · 4045

DOI: 10.1364/prj.596298 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Photonics Research, online erschienen am 20.08.2026. Verfasst von Xuhao Yu und 8 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The second near-infrared (NIR-II, 900–1880 nm) window offers superior fluorescence imaging penetration and contrast. However, its clinical application remains constrained by the lack of U.S. Food and Drug Administration (FDA)-approved NIR-II fluorophores, leaving indocyanine green (ICG) as the only clinically approved contrast agent despite its suboptimal performance in the NIR-II window. Although optical lock-in detection (OLID) is effective in suppressing noise and background, its application has remained narrowly applicable because existing implementations require fluorophores with tailored excitation or polarization sensitivities—capabilities lacking in most clinically relevant probes—thereby impeding widespread clinical translation. This work presents a probe-general NIR-II in vivo lock-in fluorescence imaging technique that suppresses noise to improve the signal-to-background ratio (SBR) and signal-to-noise ratio (SNR) by up to 2500- and 300-fold, respectively. The enhancement doubles penetration depth, reduces contrast agent dosage or excitation intensity by 95%, enables tumor visualization using FDA-approved ICG with an SNR far exceeding the Rose criterion, and improves the spatiotemporal resolution of vascular imaging. This advancement of lock-in fluorescence imaging offers a promising solution for clinical applications, particularly in NIR-II surgical navigation.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Shenzhen Key Laboratory of Functional Aggregate Materials
  • Science Technology Innovation Commission of Shenzhen Municipality
  • China Postdoctoral Science Foundation
  • USTC Center for Micro- and Nanoscale Research and Fabrication

Zitieren

APA

Yu, X., Zhang, R., Tian, Z., Chen, Y., Zhang, J., Yuan, Y., Zhao, Z., Tang, B. Z., & Hou, D. (2026). Probe-general NIR-II in vivo lock-in fluorescence imaging with superior contrast. Photonics Research, 14(9), 4045. https://doi.org/10.1364/prj.596298

Vancouver

Yu X, Zhang R, Tian Z, Chen Y, Zhang J, Yuan Y, et al. Probe-general NIR-II in vivo lock-in fluorescence imaging with superior contrast. Photonics Research. 2026;14(9):4045. doi:10.1364/prj.596298

BibTeX
@article{Yu2026,
  author = {Yu, Xuhao and Zhang, Rongyuan and Tian, Zhen and Chen, Yixuan and Zhang, Jiachen and Yuan, Yue and Zhao, Zheng and Tang, Ben Zhong and Hou, Dazhi},
  title = {Probe-general NIR-II in vivo lock-in fluorescence imaging with superior contrast},
  journal = {Photonics Research},
  year = {2026},
  volume = {14},
  number = {9},
  pages = {4045},
  doi = {10.1364/prj.596298}
}
Kostenlos starten →